Profil

Collignon Joëlle

Département des sciences biomédicales et précliniques

See author's contact details
ORCID
0000-0001-9791-8923
Main Referenced Co-authors
Jerusalem, Guy  (61)
Rorive, Andrée  (24)
Noël, Agnès  (23)
Delvenne, Philippe  (22)
Sounni, Nor Eddine  (21)
Main Referenced Keywords
breast cancer (17); oncology (16); cancer du sein (13); oncologie (13); chemotherapy (6);
Main Referenced Unit & Research Centers
GIGA‐R - Giga‐Research - ULiège [BE] (1)
Giga-Cancer - ULiège [BE] (1)
Giga-Genetics - ULiège [BE] (1)
Laboratoire de Biologie des Tumeurs et du Developpement (1)
d‐BRU - Dental Biomaterials Research Unit - ULiège [BE] (1)
Main Referenced Disciplines
Oncology (66)
Surgery (5)
Gastroenterology & hepatology (4)
Genetics & genetic processes (4)
Dermatology (2)

Publications (total 78)

The most downloaded
18828 downloads
Freres, P., Collignon, J., Gennigens, C., Scagnol, I., Rorive, A., Barbeaux, A., Coucke, P., & Jerusalem, G. (March 2010). Le cancer du sein "triple négatif". Revue Médicale de Liège, 65 (3), 120-126. https://hdl.handle.net/2268/73651

The most cited

290 citations (Scopus®)

COLLIGNON, J., LOUSBERG, L., SCHROEDER, H., & JERUSALEM, G. (2016). Triple-negative breast cancer : treatment challenges and solutions. Breast Cancer, 8, 93-107. doi:10.2147/BCTT.S69488 https://hdl.handle.net/2268/198893

Geukens, T., Brandão, M., Laenen, A., Collignon, J., Van Marcke, C., Louviaux, I., Demey, W., Van Wambeke, S., Schrijvers, D., Lecomte, S., Mebis, J., Rutten, A., Fontaine, C., Lybaert, W., Aspeslagh, S., Goeminne, J.-C., Van Den Bulck, H., Seront, E., De Backer, L., ... de Azambuja, E. (December 2022). Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future. ESMO Open, 7 (6), 100610. doi:10.1016/j.esmoop.2022.100610
Peer Reviewed verified by ORBi

Leonard, M., Collignon, J., Lousberg, L., De Roover, A., & Detry, O. (05 May 2022). Management of appendiceal malignant tumors: a single centre experience [Paper presentation]. Belgian Surgical Week 2022.
Peer reviewed

PAYE, A., Truong, A., Yip, C., Cimino, J., Blacher, S., Munaut, C., Cataldo, D., Foidart, J. M., Maquoi, E., Collignon, J., Delvenne, P., Jerusalem, G., Noël, A., & Sounni, N. E. (15 February 2022). Editor's Note: EGFR Activation and Signaling in Cancer Cells Are Enhanced by the Membrane-Bound Metalloprotease MT4-MMP. Cancer Research, 82 (4), 734. doi:10.1158/0008-5472.CAN-21-4292
Peer Reviewed verified by ORBi

Freire, M. V., MARTIN, M., Thissen, R., Van Marcke, C., SEGERS, K., SEPULCHRE, E., LEROI, N., LETE, C., FASQUELLE, C., Radermacher, J., Gokburun, Y., COLLIGNON, J., Sacré, A., JOSSE, C., PALMEIRA, L., & BOURS, V. (2022). Case Report Series: Aggressive HR Deficient Colorectal Cancers Related to BRCA1 Pathogenic Germline Variants. Frontiers in Oncology, 12, 835581. doi:10.3389/fonc.2022.835581
Peer Reviewed verified by ORBi

SALHI, L., MALAISE, O., & COLLIGNON, J. (25 November 2021). Ostéonécrose de la mâchoire : regards croisés entre une dentiste, une oncologue et un rhumatologue » [Paper presentation]. ostéonécrose de la mâchoire : regards croisés entre une dentiste, une oncologue et un rhumatologue ».

ONESTI, C. E., Schroeder, H., Rorive, A., Sautois, B., Lecocq, M., Goffin, M., Gonne, E., Collinge, A., Nicolaers, L., Wéra, O., Catot, A., Loly, C., Paulus, A., Sibille, A., Lousberg, L., Troisfontaine, F., Collignon, J., Gennigens, C., Frères, P., ... Jerusalem, G. (2021). Oncological patients' reactions to COVID-19 pandemic: A single institution prospective study. Cancer Reports, 1571. doi:10.1002/cnr2.1571
Peer reviewed

Detry, O., Troisfontaine, F., MEURISSE, N., Delwaide, J., LAMPROYE, A., WARLING, O., JADOUL, A., LOLY, C., & COLLIGNON, J. (May 2021). Prise en charge multidisciplinaire des tumeurs malignes primitives du foie. Revue Médicale de Liège, 76 (5-6), 519-524.

Lousberg, L., Collignon, J., Troisfontaine, F., PAULUS, A., VAILLANT, F., DELANNOY, P., Petignot, S., Petrossians, P., Rohmer, V., Jadoul, A., & Beckers, A. (2021). Néoplasies neuroendocrines : une nouvelle ère a l’apogée de la multidisciplinarité ! Revue Médicale de Liège, 76 (5-6), 425-431.
Editorial Reviewed verified by ORBi

de Azambuja, E., Brandão, M., Wildiers, H., Laenen, A., Aspeslagh, S., Fontaine, C., COLLIGNON, J., Lybaert, W., Verheezen, J., Rutten, A., Vuylsteke, P., Goeminne, J.-C., Demey, W., Van Beckhoven, D., Deblonde, J., Rottey, S., Geukens, T., Punie, K., Belgian Collaborative Group on COVID-19 Hospital Surveillance and the Belgian Society of Medical Oncology (BSMO), ... Wyndham-Thomas, C. (September 2020). Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis. ESMO Open, 5 (5), 000947. doi:10.1136/esmoopen-2020-000947
Peer Reviewed verified by ORBi

ONESTI, C. E., SCHROEDER, H., RORIVE, A., SAUTOIS, B., LECOCQ, M., Goffin, M., GONNE, E., COLLINGE, A., NICOLAERS, L., WERA, O., Catot, A., LOLY, C., PAULUS, A., SIBILLE, A., LOUSBERG, L., Troisfontaine, F., COLLIGNON, J., GENNIGENS, C., FRERES, P., & JERUSALEM, G. (2020). How do oncological patients perceive the Covid-19 (SARS-CoV-2) pandemic ? Experience from CHU Liege in Belgium [Poster presentation]. ESMO Virtual Congress 2020, Madrid, Spain.

LECOCQ, M., ONESTI, C. E., SCHROEDER, H., RORIVE, A., Goffin, M., GONNE, E., SAUTOIS, B., Catot, A., WERA, O., NICOLAERS, L., COLLINGE, A., Collignon, J., FRERES, P., POLUS, M., DUYSINX, B., VAILLANT, F., GENNIGENS, C., MARCHAL, N., PONCIN, A., & JERUSALEM, G. (2020). Risk of SARS-CoV-2 infection and outcome after infection : Experience from the day-care unit at CHU Liege in Belgium [Poster presentation]. ESMO Virtual Congress 2020, Madrid, Spain.

LOUSBERG, L., COLLIGNON, J., & DETRY, O. (January 2020). Appendiceal neuroendrocrine neoplasms: incidentaloma or something we should worry about? Current Opinion in Gastroenterology, 36 (1), 48-54. doi:10.1097/MOG.0000000000000597
Peer Reviewed verified by ORBi

DAMSIN, T., COLLIGNON, J., LEBAS, E., Libon, F., DEZFOULIAN, B., & NIKKELS, A. (January 2019). Comment je traite... Les toxicités mucocutanées des thérapies ciblées en oncologie. Revue Médicale de Liège, 01, 7-14.
Peer reviewed

FOIDART, P., Yip, C., Radermacher, J., Blacher, S., Lienard, M., MONTERORUIZ, L., Maquoi, E., Montaudon, E., Chateau-Joubert, S., COLLIGNON, J., Coibion, M., Jossa, V., Marangoni, E., Noël, A., Sounni, N. E.* , & JERUSALEM, G.*. (2019). Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy. Clinical Cancer Research. doi:10.1158/1078-0432.CCR-18-1880
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Wenric, S., El Guendi, S., CABERG, J.-H., Bezzaou, W., Fasquelle, C., Charloteaux, B., Karim, L., Hennuy, B., FRERES, P., COLLIGNON, J., BOUKERROUCHA, M., SCHROEDER, H., Olivier, F., Jossa, V., JERUSALEM, G., JOSSE, C., & BOURS, V. (May 2017). Transcriptome wide analysis of natural antisense transcripts shows potential role in breast cancer [Poster presentation]. 50th meeting of the European Society of Human Genetics, Copenhagen, Denmark.

Wenric, S., ElGuendi, S., CABERG, J.-H., Bezzaou, W., Fasquelle, C., Charloteaux, B., Karim, L., Hennuy, B., FRERES, P., COLLIGNON, J., BOUKERROUCHA, M., SCHROEDER, H., OLIVIER, F., Jossa, V., Jerusalem, G., JOSSE, C., & Bours, V. (2017). Transcriptome-wide analysis of natural antisense transcripts shows their potential role in breast cancer. Scientific Reports, 7 (1), 17452. doi:10.1038/s41598-017-17811-2
Peer Reviewed verified by ORBi

VAN DAELE, D., Honoré, P., COLLIGNON, J., POLUS, M., LOLY, C., MUTIJIMA NZARAMBA, E., De Roover, A., Coucke, P., Louis, E., & Martinive, P. (2017). Comment je traite... les cancers localises de l'oesophage. Etat actuel des donnees et strategie therapeutique. 1ere partie : le point sur les approches chirurgicales et non chirurgicales. Revue Médicale de Liège, 72 (2), 58-63.
Peer reviewed

VAN DAELE, D., Honoré, P., COLLIGNON, J., POLUS, M., LOLY, C., MUTIJIMA NZARAMBA, E., De Roover, A., Coucke, P., Louis, E., & Martinive, P. (2017). Comment je traite... les cancers localises de l'oesophage. Etat actuel des donnees et strategie therapeutique. 2eme partie : l'interet des approches multimodales avec ou sans chirurgie. Revue Médicale de Liège, 72 (4), 168-174.
Peer reviewed

Yip, C., Foidart, P., Somja, J., Truong, A., Lienard, M., Feyereisen, E., SCHROEDER, H., GOFFLOT, S., Donneau, A.-F., COLLIGNON, J., Delvenne, P., Sounni, N. E., Jerusalem, G., & Noël, A. (2017). MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib. British Journal of Cancer. doi:10.1038/bjc.2017.23
Peer Reviewed verified by ORBi

COLLIGNON, J., LOUSBERG, L., SCHROEDER, H., & JERUSALEM, G. (2016). Triple-negative breast cancer : treatment challenges and solutions. Breast Cancer, 8, 93-107. doi:10.2147/BCTT.S69488
Peer Reviewed verified by ORBi

GONNE, E., COLLIGNON, J., JERUSALEM, G., & GENNIGENS, C. (2016). Le carcinome de site primitif inconnu, une entité pas si rare. Revue Médicale de Liège, 71 (10), 449-454.
Peer reviewed

LOUSBERG, L., COLLIGNON, J., & Jerusalem, G. (2016). Resistance to therapy in estrogen receptor positive and human epidermal growth factor 2 positive breast cancers: progress with latest therapeutic strategies. Therapeutic Advances in Medical Oncology, 8 (6), 429-449. doi:10.1177/1758834016665077
Peer Reviewed verified by ORBi

Freres, P.* , Wenric, S.* , BOUKERROUCHA, M., Fasquelle, C., Thiry, J., Bovy, N., Struman, I., Geurts, P., COLLIGNON, J., SCHROEDER, H., KRIDELKA, F., LIFRANGE, E., Jossa, V., Bours, V.* , Josse, C.* , & JERUSALEM, G.*. (2015). Circulating microRNA-based screening tool for breast cancer. Oncotarget. doi:10.18632/oncotarget.6786
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Yip, C., FOIDART, P., SOMJA, J., Truong, A., COLLIGNON, J., DELVENNE, P., Sounni, N. E., JERUSALEM, G., & Noël, A. (03 December 2015). MT4-MMP, a potential prognostic factor in triple negative breast cancer [Paper presentation]. Séminaire des chercheurs Télévie 2016, Gembloux, Belgium.

Yip, C., PAYE, A., Truong, A., Cimino, J., COLLIGNON, J., DELVENNE, P., Jerusalem, G., Sounni, N. E., & Noël, A. (11 September 2015). Clinical significance of MT4-MMP and EGFR expression in Breast Cancer [Paper presentation]. EDT-Cancérologie Expérimentale Annual symposium « New advances in animal models in cancerology ».

Yip, C., FOIDART, P., SOMJA, J., Truong, A., COLLIGNON, J., DELVENNE, P., Sounni, N. E., JERUSALEM, G., & Noël, A. (September 2015). MT4-MMP, a potential therapeutic target in triple negative breast cancer [Poster presentation]. 2nd international society of cancer metabolism meeting - METABOLISM and MICROENVIRONMENT in CANCER PLASTICITY, Venise, Italy.

Yip, C., PAYE, A., Truong, A., Cimino, J., COLLIGNON, J., DELVENNE, P., JERUSALEM, G., Sounni, N. E., & Noël, A. (June 2015). Clinical significance of MT4-MMP and EGFR expression in Breast Cancer [Paper presentation]. Biomedica Life Science Summit, Genk, Belgium.

Perez Palacios, A., Blomme, A., Boutry, S., Doumont, G., Sherer, F., Van Simaeys, G., Debois, D., JERUSALEM, G., COLLIGNON, J., DELVENNE, P., DETRY, O., De Pauw, E., Muller, R., Goldman, S., Castronovo, V., & Turtoi, A. (March 2015). Metabolomic, proteomic and preclinical imaging of patient-derived tumor xenografts for improving treatment of liver metastases patients. Acta Gastro-Enterologica Belgica, 78 (1), 134.
Peer Reviewed verified by ORBi

Yip, C., PAYE, A., Truong, A., Cimino, J., COLLIGNON, J., DELVENNE, P., JERUSALEM, G., Sounni, N. E., & Noël, A. (11 February 2015). Clinical significance of MT4-MMP and EGFR expression in Breast Cancer [Paper presentation]. Séminaire des chercheurs Télévie 2015, Bruxelles, Belgium.

Yip, C., PAYE, A., Truong, A., Cimino, J., COLLIGNON, J., DELVENNE, P., JERUSALEM, G., Sounni, N. E., & Noël, A. (31 January 2015). Clinical significance of MT4-MMP and EGFR expression in Breast Cancer [Paper presentation]. ABEC - Tumor Metabolism and Mitochondria, Bruxelles, Belgium.

Boukerroucha, M., Josse, C., El Guendi, S., FRERES, P., Marée, R., Wenric, S., SEGERS, K., COLLIGNON, J., JERUSALEM, G., & BOURS, V. (2015). Genetic study of triple negative breast cancers [Poster presentation]. Impakt Breast Cancer Conference, Brussels, Belgium. doi:10.1093/annonc/mdv116.11

Jerusalem, G., RORIVE, A., & COLLIGNON, J. (2015). Chemotherapy options for patients suffering from heavily pretreated metastatic breast cancer. Future Oncology, 11 (12), 1775-89. doi:10.2217/fon.15.80
Peer Reviewed verified by ORBi

JERUSALEM, G., COLLIGNON, J., Josse, C., SCHROEDER, H., RORIVE, A., FRERES, P., LAMBERT, F., KOOPMANSCH, B., PONCIN, A., & BOURS, V. (2015). Cancer du sein : de la thérapie ciblée à la médecine personnalisée. Revue Médicale de Liège, 70 (5-6), 269-276.
Peer reviewed

FRERES, P., GONNE, E., COLLIGNON, J., GIOT, J.-B., GENNIGENS, C., & JERUSALEM, G. (2015). Prise en charge de la neutropénie fébrile chez le patient cancéreux. Revue Médicale de Liège, 70 (4), 195-200.
Peer reviewed

COLIN, P.-E., SCHROEDER, H., GONNE, E., Hanocq, F., ANDRE, C., RORIVE, A., Jerusalem, G., & COLLIGNON, J. (2015). BIOPSIE DES LESIONS SUSPECTES CHEZ LES PATIENTS AYANT PRESENTE UN CANCER DU SEIN. Revue Médicale de Liège, 70 (11), 563-8.
Peer reviewed

SCHROEDER, H., Hanocq, F., COLLIGNON, J., Colin, P.-E., Depuis, Z., Triffaux, F., RORIVE, A., & JERUSALEM, G. (2015). Cancer du sein: intérêt du bilan d’extension par imagerie lors du diagnostic initial et du suivi les trois premières années après le diagnostic. Revue Médicale de Liège, 70 (3), 140-147.
Peer reviewed

VAN DAELE, D., Martinive, P., LOLY, C., POLUS, M., COLLIGNON, J., GAST, P., Louis, E., & Van Laethem, J.-L. (2015). COMMENT JE TRAITE ... Point de vue critique sur l'approche actuelle du cancer du pancreas localisé. Revue Médicale de Liège, 70 (11), 540-5.
Peer reviewed

Boukerroucha, M., Josse, C., El Guendi, S., Boujemla, B., Freres, P., Marée, R., Wenric, S., SEGERS, K., COLLIGNON, J., Jerusalem, G., & Bours, V. (2015). Evaluation of BRCA1-related molecular features and microRNAs as prognostic factors for triple negative breast cancers. BMC Cancer, 15 (1), 755. doi:10.1186/s12885-015-1740-9
Peer Reviewed verified by ORBi

Paye, A., Truong, A., Yip, C., Cimino, J., Blacher, S., Munaut, C., Cataldo, D., Foidart, J.-M., Maquoi, E., COLLIGNON, J., Delvenne, P., Jerusalem, G., Noël, A.* , & Sounni, N. E.*. (October 2014). EGFR activation and signaling in cancer cells are enhanced by the membrane-bound metalloprotease MT4-MMP. Cancer Research, 74 (23), 6758-70. doi:10.1158/0008-5472.CAN-13-2994
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Yip, C., PAYE, A., Truong, A., Cimino, J., COLLIGNON, J., DELVENNE, P., JERUSALEM, G., Sounni, N. E., & Noël, A. (30 September 2014). Clinical significance of MT4-MMP and EGFR expression in Breast Cancer [Paper presentation]. Ecole Doctorale Thematique En Cancerologie Experimentale, Liege, Belgium.

Yip, C., PAYE, A., Truong, A., Cimino, J., COLLIGNON, J., DELVENNE, P., JERUSALEM, G., Sounni, N. E., & Noël, A. (19 May 2014). Clinical significance of MT4-MMP and EGFR expression in Breast Cancer [Paper presentation]. GIGA-Cancer Day 2014, Liege, Belgium.

Yip, C., PAYE, A., Truong, A., Cimino, J., COLLIGNON, J., DELVENNE, P., JERUSALEM, G., Sounni, N. E., & Noël, A. (27 January 2014). Study of the pro-tumoral effects of MT4-MMP [Paper presentation]. GIGA-Day 2014, Liege, Belgium.

MARTINIVE, P., ALLEPAERTS, S., VAN DAELE, D., POLUS, M., COIMBRA MARQUES, C., KOHNEN, L., COLLIGNON, J., LENNERTS, E., VANDERICK, J., & COUCKE, P. (2014). LA RADIOTHÉRAPIE DANS LE CANCER DU RECTUM CHEZ LA PERSONNE ÂGÉE: Quel bénéfice pour le traitement ? Revue Médicale de Liège, 69 (Supp 1), 47-52.
Peer reviewed

MARTINIVE, P., VAN DAELE, D., LENNERTS, E., ALLEPAERTS, S., POLUS, M., COIMBRA MARQUES, C., KOHNEN, L., VANDERICK, J., COLLIGNON, J., & COUCKE, P. (2014). LA RADIOTHÉRAPIE DANS LE CANCER DU RECTUM : quand, comment et pourquoi ? Revue Médicale de Liège, 69 (Supp 1), 37-46.
Peer reviewed

Jerusalem, G., RORIVE, A., & COLLIGNON, J. (2014). Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes. Breast Cancer, 6, 43-57. doi:10.2147/BCTT.S38679
Peer Reviewed verified by ORBi

JERUSALEM, G., RORIVE, A., & COLLIGNON, J. (2014). Le médicament du mois : Everolimus (Afinitor) dans le traitement du cancer du sein métastatique. Revue Médicale de Liège, 69 (9), 510-517.
Peer reviewed

Yip, C., PAYE, A., Truong, A., Cimino, J., COLLIGNON, J., DELVENNE, P., Jerusalem, G., Sounni, N. E., & Noël, A. (05 December 2013). Study of the pro-tumoral effects of MT4-MMP [Paper presentation]. Séminaire des chercheurs Télévie 2014, Bruxelles, Belgium.

Yip, C., PAYE, A., Truong, A., Cimino, J., COLLIGNON, J., DELVENNE, P., JERUSALEM, G., Sounni, N. E., & Noël, A. (13 September 2013). Study of the pro-tumoral effects of MT4-MMP [Paper presentation]. Annual Mini Symposium 2013, Liege, Belgium.

Yip, C., PAYE, A., Truong, A., Cimino, J., COLLIGNON, J., DELVENNE, P., JERUSALEM, G., Sounni, N. E., & Noël, A. (02 July 2013). Regulation of breast cancer cell properties by MT4-MMP [Paper presentation]. Mini symposium "Tumor Microenvironment", Liege, Belgium.

Yip, C., PAYE, A., Truong, A., Cimino, J., COLLIGNON, J., DELVENNE, P., JERUSALEM, G., Sounni, N. E., & Noël, A. (17 May 2013). Regulation of breast cancer cell properties by MT4-MMP [Paper presentation]. GIGA-Cancer Day 2013.

Yip, C., PAYE, A., Truong, A., Cimino, J., COLLIGNON, J., DELVENNE, P., JERUSALEM, G., Sounni, N. E., & Noël, A. (29 January 2013). Regulation of breast cancer cell properties by MT4-MMP [Paper presentation]. GIGA-Day 2013, Liege, Belgium.

Yip, C., PAYE, A., Truong, A., Cimino, J., COLLIGNON, J., DELVENNE, P., JERUSALEM, G., Sounni, N. E., & Noël, A. (29 January 2013). Regulation of breast cancer cell properties by MT4-MMP [Paper presentation]. EDT cancérologie.

COLSON, F., SIGHA, B., ARRESE ESTRADA, J., QUATRESOOZ, P., RORIVE, A., COLLIGNON, J., & NIKKELS, A. (2013). Paclitaxel-Related Lymphedema and Scleroderma-Like Skin Changes. Journal of Clinical Case Reports, 3 (11).

Yip, C., PAYE, A., Truong, A., Cimino, J., COLLIGNON, J., DELVENNE, P., JERUSALEM, G., Sounni, N. E., & Noël, A. (10 December 2012). Regulation of breast cancer cell properties by MT4-MMP [Paper presentation]. Séminaire des chercheurs Télévie 2013, Liege, Belgium.

Yip, C., PAYE, A., Truong, A., Cimino, J., COLLIGNON, J., DELVENNE, P., JERUSALEM, G., Sounni, N. E., & Noël, A. (09 November 2012). Regulation of breast cancer cell properties by MT4-MMP [Paper presentation]. Fall meeting of the belgian society for biochemistry and molecular biology - "Metabolomics... To Do What?", Namur, Belgium.

Yip, C., PAYE, A., Truong, A., Cimino, J., COLLIGNON, J., DELVENNE, P., JERUSALEM, G., Sounni, N. E., & Noël, A. (13 October 2012). Regulation of breast cancer cell properties by MT4-MMP [Paper presentation]. Fall meeting of the belgian society for cell and developmental biology - epidermal cell biology, Namur, Belgium.

COLLIGNON, J., & JERUSALEM, G. (2012). Les traitements cibles remplaceront-ils la chimiotherapie? Revue Médicale de Liège, 67 Spec No, 29-36.
Peer reviewed

Courtois, A.-C., COLLIGNON, J., BRUYERE, P.-J., Crielaard, J.-M., & Kaux, J.-F. (May 2011). Metastase unique cervicale d'un cancer du sein. Revue Médicale de Liège, 66 (5-6), 285-287.
Peer reviewed

MARTIN, M., COLLIGNON, J., RORIVE, A., ANDRE, C., BOURHABA, M., ALLEPAERTS, S., COUCKE, P., LIFRANGE, E., & JERUSALEM, G. (2011). Le cancer du sein de la femme âgée. Revue Médicale de Liège, 66 (5-6), 400-408.
Peer reviewed

COLLIGNON, J., RORIVE, A., MARTIN, M., ANDRE, C., MAWEJA, S., LIFRANGE, E., COUCKE, P., & JERUSALEM, G. (2011). Chimiothérapie et cancer du sein. Revue Médicale de Liège, 66 (5-6), 372-378.
Peer reviewed

RORIVE, A., COLLIGNON, J., MARTIN, M., ANDRE, C., JERUSALEM, G., & COUCKE, P. (2011). Cancer du sein et métastases cérébrales. Revue Médicale de Liège, 66 (5-6), 299-305.
Peer reviewed

LIFRANGE, E., ANDRE, C., BLERET, V., COLLIGNON, J., COUCKE, P., CUSUMANO, G., DESREUX, J., HERMAN, P., JERUSALEM, G., KRIDELKA, F., MARTIN, M., RORIVE, A., Van Cauwenberge, J.-R., & COLIN, C. (2011). Hormonothérapie du cancer du sein. Revue Médicale de Liège, 66 (5-6), 367-371.
Peer reviewed

COLLIGNON, J., Struman, I., Tabruyn, S., Josse, C., Boukerroucha, M., JERUSALEM, G., & BOURS, V. (2011). Aspects moléculaires du cancer du sein triple négatif et les implications thérapeutiques. Revue Médicale de Liège, 66 (5-6), 393-396.
Peer reviewed

COUCKE, P., JANSEN, N., JANVARY, Z. L., LOUIS, C., VANDERICK, J., RORIVE, A., COLLIGNON, J., LIFRANGE, E., MAWEJA, S., & JERUSALEM, G. (2011). Accelerated partial breast irradiation: state of the art. Belgian Journal of Medical Oncology, 5 (1), 3-7.
Peer Reviewed verified by ORBi

WITHOFS, N., COLLIGNON, J., RORIVE, A., JERUSALEM, G., & HUSTINX, R. (2011). Hétérogénéité des métastases osseuses du cancer du sein : cas clinique illustrant l'intérêt de combiner différentes techniques d'imagerie. Revue Médicale de Liège, 66 (5-6), 288-290.
Peer reviewed

Gilles, C., COLLIGNON, J., Noël, A., Jerusalem, G., & Foidart, J.-M. (2011). Cellules Tumorales Circulantes : détection, caractérisation et intérêts cliniques. Revue Médicale de Liège, 66 (5-6), 279-84.
Peer reviewed

COUCKE, P., LAKOSI, F., RORIVE, A., JANVARY, Z. L., COLLIGNON, J., JANSEN, N., ANDRE, C., & JERUSALEM, G. (2011). Radiothérapie et cancer du sein : "standards" de traitement, prédiction de rechute locale et questions ouvertes. Revue Médicale de Liège, 66 (5-6), 320-325.
Peer reviewed

JERUSALEM, G., COLLIGNON, J., RORIVE, A., LIFRANGE, E., ANDRE, C., MARTIN, M., MAWEJA, S., & COUCKE, P. (2011). Traitements ciblés dans le cancer du sein. Revue Médicale de Liège, 66 (5-6), 379-384.
Peer reviewed

ANDRE, C., COLLIGNON, J., RORIVE, A., MARTIN, M., MAWEJA, S., LIFRANGE, E., COUCKE, P., & JERUSALEM, G. (2011). Le cancer du sein chez la femme jeune. Revue Médicale de Liège, 66 (5-6), 397-399.
Peer reviewed

LOUSBERG, L., SOMJA, J., COLLIGNON, J., Gilles, C., & JERUSALEM, G. (2011). A propos d'un cas de rechute tardive de cancer du sein après traitement adjuvant. Revue Médicale de Liège, 66 (5-6), 306-310.
Peer reviewed

WITHOFS, N., COLLIGNON, J., & HUSTINX, R. (2011). Imagerie des métastases osseuses du cancer du sein. Revue Médicale de Liège, 66 (5-6), 291-298.
Peer reviewed

Collignon, J., Gennigens, C., & Jerusalem, G. (July 2010). Assessment of Response to Therapy for Bone Metastases : Is it still a challenge in oncology ? PET Clinics, 5 (3), 311-326. doi:10.1016/j.cpet.2010.05.002
Peer Reviewed verified by ORBi

Freres, P., Collignon, J., Gennigens, C., Scagnol, I., Rorive, A., Barbeaux, A., Coucke, P., & Jerusalem, G. (March 2010). Le cancer du sein "triple négatif". Revue Médicale de Liège, 65 (3), 120-126.
Peer reviewed

Bleret, V., Collignon, J., Coucke, P., Cusumano, G., DESREUX, J., Herman, P., Jerusalem, G., Maweja, S., Remacle, N., Rorive, A., & Lifrange, E. (2010). L'observance au traitement de longue durée : le cas particulier de l'hormonothérapie adjuvante du cancer du sein. Revue Médicale de Liège, 65 (5-6), 405-408.
Peer reviewed

Coucke, P., Jansen, N., Collignon, J., Janvary, Z. L., Rorive, A., Vanderick, J., & Jerusalem, G. (January 2010). Pourquoi les traitements de radiothérapie adjuvante pour cancer du sein ne comptent-ils plus autant de séances ? Revue Médicale de Liège, 65 (1), 10-14.
Peer reviewed

Collignon, J., Gennigens, C., Rorive, A., Coucke, P., Lifrange, E., Maweja, S., Fillet, G., & Jerusalem, G. (May 2009). ANTICORPS MONOCLONAUX ET CANCER DU SEIN: Actualités thérapeutiques. Revue Médicale de Liège, 64 (5-6), 279-83.
Peer reviewed

Gennigens, C., Collignon, J., Jerusalem, G., Rorive, A., & Sautois, B. (2009). Anticorps monoclonaux a usage therapeutique en hemato-oncologie. Generalites. Revue Médicale de Liège, 64 (5-6), 264-7.
Peer reviewed

GONNE, E., Collignon, J., Kurth, W., Thiry, A., Henry, F., Jerusalem, G., & Gennigens, C. (2009). Angiosarcome sur lymphoedeme chronique: un cas de syndrome de Stewart-Treves. Revue Médicale de Liège, 64 (7-8), 409-13.
Peer reviewed

Contact ORBi